--PARAGON BIOMEDICAL WAS ACQUIRED BY CLINIPACE WORLDWIDE IN SEPTEMBER 2012-- At Clinipace Worldwide, we believe that waiting 15 years, for a drug or medical device that can save lives today, is too long. That's why 10 years ago, we pioneered an innovative service model that has transformed drug and medical device development. Powered by TEMPO™, our proprietary eClinical platform, our team of experts bring extensive therapeutic knowledge and insight into assisting life science, biotechnology and medical device firms in developing and executing regulatory strategies, clinical development, and post-approval research to drug and medical device trials. Our therapeutic expertise includes cardiovascular & metabolic diseases, central nervous system, dermatology, gastroenterology, immunology, infectious diseases, nephrology, oncology, respiratory, rheumatology, & vaccines. Clinipace is headquartered in Research Triangle Park, North Carolina (the global epicenter of technological innovation) with additional regional offices in North America, Europe, Middle East & Asia, and South America. Things To Know About Clinipace Worldwide: • We were named to Forbes' 2012 List of America's Most Promising Companies • We’ve been named to Inc. Magazine’s Inc. 500 List for 3 consecutive years • We’re the first digital clinical research organization (dCRO) • Our teams have managed 1,200+ global clinical research, strategic product development, regulatory, and GxP/CMC/QA projects
View Top Employees from Paragon Biomedical (Now Clinipace Worldwide)Website | https://www.clinipace.com |
Revenue | $169 million |
Funding | $132.8 million |
Employees | 46 (29 on RocketReach) |
Founded | 1989 |
Address | 3800 Paramount Pkwy, Ste 100, Morrisville, North Carolina 27560, US |
Phone | (919) 224-8800 |
Industry | Research, Medical Testing & Clinical Laboratories, Contract Research Organization, Healthcare, CRO, Pharmaceuticals, Medical Devices, Regulatory, Clinical Trials, Biotechnology, Clinical Development, Drug Development, Medical Device Development |
Web Rank | 2 Million |
Keywords | Clinipace, Ec Approval Process In Clinical Trials, Infectious Disease Impacting Low Income Countries The Most, Clinical Trial Recruitment And Social Media Marketing Use "Slow Adoption", Companies Bought By Clinipace Worldwide, Clinipace Worldwide |
Competitors | Cliantha Research Limited, Novum Pharmaceutical Research Services, PSI CRO AG, Pharm-Olam International, Premier Research |
SIC | SIC Code 7389 Companies, SIC Code 73 Companies, SIC Code 738 Companies |
NAICS | NAICS Code 54199 Companies, NAICS Code 5419 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Paragon Biomedical (Now Clinipace Worldwide) employee's phone or email?
The Paragon Biomedical (Now Clinipace Worldwide) annual revenue was $169 million in 2023.
29 people are employed at Paragon Biomedical (Now Clinipace Worldwide).
Paragon Biomedical (Now Clinipace Worldwide) is based in Morrisville, North Carolina.
The NAICS codes for Paragon Biomedical (Now Clinipace Worldwide) are [54199, 5419, 54, 541].
The SIC codes for Paragon Biomedical (Now Clinipace Worldwide) are [7389, 73, 738].